Cargando…
T Cells Induce Pre-Metastatic Osteolytic Disease and Help Bone Metastases Establishment in a Mouse Model of Metastatic Breast Cancer
Bone metastases, present in 70% of patients with metastatic breast cancer, lead to skeletal disease, fractures and intense pain, which are all believed to be mediated by tumor cells. Engraftment of tumor cells is supposed to be preceded by changes in the target tissue to create a permissive microenv...
Autores principales: | Monteiro, Ana Carolina, Leal, Ana Carolina, Gonçalves-Silva, Triciana, Mercadante, Ana Carolina T., Kestelman, Fabiola, Chaves, Sacha Braun, Azevedo, Ricardo Bentes, Monteiro, João P., Bonomo, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730734/ https://www.ncbi.nlm.nih.gov/pubmed/23935856 http://dx.doi.org/10.1371/journal.pone.0068171 |
Ejemplares similares
-
A T Cell View of the Bone Marrow
por: Bonomo, Adriana, et al.
Publicado: (2016) -
Ra223 in Bone Metastases with Osteolytic Activity
por: Costa, Renato Patrizio, et al.
Publicado: (2018) -
Matrix Rigidity Induces Osteolytic Gene Expression of Metastatic Breast Cancer Cells
por: Ruppender, Nazanin S., et al.
Publicado: (2010) -
Elevated Pentraxin 3 in bone metastatic breast cancer is correlated with osteolytic function
por: Choi, Bongkun, et al.
Publicado: (2014) -
Cancer of the prostate presenting with diffuse osteolytic metastatic bone lesions: a case report
por: Segamwenge, Innocent Lule, et al.
Publicado: (2012)